These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. A six-month open safety assessment of a naproxen suspension formulation in the therapy of juvenile rheumatoid arthritis. Laxer RM; Silverman ED; St-Cyr C; Tran MT; Lingam G Clin Ther; 1988; 10(4):381-7. PubMed ID: 3079006 [TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drug-induced pseudoporphyria: a case series. LaDuca JR; Bouman PH; Gaspari AA J Cutan Med Surg; 2002; 6(4):320-6. PubMed ID: 12118363 [TBL] [Abstract][Full Text] [Related]
16. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. De Silva B; Banney L; Uttley W; Luqmani R; Schofield O Pediatr Dermatol; 2000; 17(6):480-3. PubMed ID: 11123786 [TBL] [Abstract][Full Text] [Related]
17. [Naprosyn in the treatment of children with rheumatoid arthritis]. Siemieńska-Rywik S; Dubrowski M; Rostropowicz-Denisiewicz K; Polakowa I Pediatr Pol; 1984 Oct; 59(10):847-51. PubMed ID: 6398422 [No Abstract] [Full Text] [Related]